IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 106.57%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.97B
AUM Growth
+$601M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$52.5M
2
+$51M
3
+$45.3M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$37.4M
5
DXCM icon
DexCom
DXCM
+$32.3M

Top Sells

1
+$63.9M
2
+$40.4M
3
+$30.1M
4
BTSG icon
BrightSpring Health Services
BTSG
+$13.4M
5
PFE icon
Pfizer
PFE
+$12.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
51
Quest Diagnostics
DGX
$22.1B
$13M 0.66%
75,000
-10,000
SANA icon
52
Sana Biotechnology
SANA
$876M
$12.2M 0.62%
3,000,000
+1,000,000
TARA icon
53
Protara Therapeutics
TARA
$306M
$12M 0.61%
2,250,000
+850,000
PRAX icon
54
Praxis Precision Medicines
PRAX
$8.63B
$11.8M 0.6%
+40,000
DNTH icon
55
Dianthus Therapeutics
DNTH
$3.76B
$11.3M 0.57%
275,000
+125,000
NVST icon
56
Envista
NVST
$4.26B
$10.9M 0.55%
500,000
-50,000
EHC icon
57
Encompass Health
EHC
$10.7B
$10.6M 0.54%
100,000
-100,000
ORIC icon
58
Oric Pharmaceuticals
ORIC
$1.41B
$9.82M 0.5%
1,200,000
+300,000
CRL icon
59
Charles River Laboratories
CRL
$8.24B
$8.98M 0.45%
45,000
-15,000
CELC icon
60
Celcuity
CELC
$5.42B
$7.98M 0.4%
+80,000
INSP icon
61
Inspire Medical Systems
INSP
$1.7B
$6.92M 0.35%
75,000
-45,000
ANRO icon
62
Alto Neuroscience
ANRO
$649M
$6.67M 0.34%
375,000
-25,000
LNTH icon
63
Lantheus
LNTH
$5.52B
$6.66M 0.34%
+100,000
ARWR icon
64
Arrowhead Research
ARWR
$8.29B
$6.64M 0.34%
100,000
-125,000
BRKR icon
65
Bruker
BRKR
$5.57B
$5.89M 0.3%
+125,000
NRIX icon
66
Nurix Therapeutics
NRIX
$1.64B
$5.69M 0.29%
300,000
-50,000
ELAN icon
67
Elanco Animal Health
ELAN
$11.8B
$5.66M 0.29%
250,000
-550,000
APLS icon
68
Apellis Pharmaceuticals
APLS
$2.51B
$5.02M 0.25%
200,000
-50,000
RZLT icon
69
Rezolute
RZLT
$307M
$4.72M 0.24%
2,000,000
DFTX
70
Definium Therapeutics
DFTX
$1.9B
$4.69M 0.24%
+350,000
SNDX icon
71
Syndax Pharmaceuticals
SNDX
$2.13B
$4.2M 0.21%
+200,000
MAZE
72
Maze Therapeutics
MAZE
$2.46B
$4.14M 0.21%
+100,000
EYPT icon
73
EyePoint Inc
EYPT
$1.28B
$3.65M 0.19%
+200,000
IKT icon
74
Inhibikase Therapeutics
IKT
$236M
$3.59M 0.18%
+1,750,000
VKTX icon
75
Viking Therapeutics
VKTX
$4.01B
$3.52M 0.18%
+100,000
1 2
3
4